CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma-Reference-Cited by-同舟云学术

CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma

Published:2005-07 Issue:1-2 Volume:574 Page:112-123
ISSN:0027-5107
Container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
language:en
Short-container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Author:

Gajecka Marzena,Rydzanicz Malgorzata,Jaskula-Sztul Renata,Kujawski Maciej,Szyfter Witold,Szyfter Krzysztof

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics,Molecular Biology

Reference56 articles.

1. Smoking and drinking in relation to oral and pharyngeal cancer;Blot;Cancer Res.,1998

2. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case–referent study in Sweden;Lewin;Cancer,1998

3. Tobacco and alcohol and the risk of head and neck cancer;Maier;Clin. Invest.,1992

4. Tobacco, alcohol, asbestos and occupational risk factors for laryngeal cancer;Muscat;Cancer,1992

5. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers;Bartsch;Cancer Epidemiol. Biomarkers Prev.,2000

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of inflammation in cancer by dietary eicosanoids;Pharmacology & Therapeutics;2023-08

2. Pharmacogenomics of Drug-Metabolizing Enzymes;Pharmacogenomics in Clinical Practice;2023

3. Gene polymorphisms and risk of head and neck squamous cell carcinoma: a systematic review;Reports of Practical Oncology and Radiotherapy;2022-12-29

4. Perspectives on the Use of Toxicogenomics to Assess Environmental Risk;Frontiers in Bioscience-Landmark;2022-10-28

5. Cytochrome P450 polymorphisms with impact in cardiovascular drugs metabolisms in European populations;Human Gene;2022-09